ID27, ID28, ID29. Bilirubin (Total, Direct, Indirect). (μmol/l or mg/dl)
Bilirubin comes from the breakdown of
senescent red blood cells and predominantly circulates in its unconjugated form
tightly bound to albumin. Unconjugated bilirubin is not excreted in the urine.
Conjugation by uridine 5’-diphospho (UDP)-glucuronosyltransferase makes
bilirubin water-soluble (conjugated bilirubin), allowing it to be excreted in
bile where it is converted by bacteria in the colon to urobilinogen, which is
subsequently excreted in the urine and stool. The absence of urobilinogen gives
stool its classic clay-colored appearance in those with impaired bile flow.1
Fractionation of the bilirubin level (total
serum bilirubin) to conjugated/direct (~30% of the total serum bilirubin) and
unconjugated/indirect (~70% of the total serum bilirubin) forms is not done
routinely as many laboratories only report total serum bilirubin, which is the
sum of conjugated and unconjugated portions.
Abnormalities. Disorders or diseases
caused or related.
Fractionation of total bilirubin is most
helpful when the ALT, AST, and alkaline phosphatase levels are normal or near
normal. If the total bilirubin is elevated and fractionation shows the majority
of the elevation is unconjugated bilirubin, hepatocellular disease is unlikely
to be the explanation. Conjugated bilirubin elevations are present in
hepatocellular disorders as well as cholestatic disorders (e.g biliary
obstruction) with impairment in bile flow.1
Total bilirubin levels almost never exceed
6 mg/dl and are usually <3 mg/dl. Fasting or significant illness can
increase the unconjugated bilirubin by 2- to 3-fold, that in turn, will
decrease with eating or administration of phenobarbital.1
Table ID27.1. Causes of elevated Bilirubin
Elevated unconjugated
bilirubin (Indirect Bilirubin) |
||
Gilbert’s syndrome Crigler-Najjar syndrome Hemolysis (intravascular and
extravascular) Ineffective erythropoiesis Resorption of large hematomas |
Neonatal jaundice Hyperthyroidism Medications Post-blood transfusion |
|
Elevated conjugated
bilirubin (Direct Bilirubin) |
||
Bile duct obstruction Choledocholithiasis Malignant obstruction Bile duct flukes Bile duct stricture AIDS cholangiopathy Viral hepatitis Toxic hepatitis Medications or drug-induced liver injury Acute alcoholic hepatitis Ischemic hepatitis Cirrhosis Primary biliary cirrhosis Infiltrative diseases of the liver Sarcoid Granulomatous hepatitis Tuberculosis Metastatic cancer Lymphoma |
PSC (primary sclerosing cholangitis) Hepatocellular carcinoma Wilson disease (especially fulminant
Wilson’s disease) Autoimmune hepatitis Ischemic hepatitis Congestive hepatopathy Sepsis TPN (total parenteral nutrition) Intrahepatic cholestasis of pregnancy Benign post-operative jaundice ICU or multifactorial jaundice Benign recurrent cholestasis Vanishing bile duct syndrome Ductopenia Dubin-Johnson syndrome Rotor syndrome Sickle cell liver crisis Hemophagocytic lymphohistiocytosis
|
|
Elevated unconjugated or indirect bilirubin is
due to over-production of bilirubin (such as hemolysis), decreased hepatic
uptake, or decreased hepatic conjugation. The most common cause of elevated
unconjugated bilirubin is Gilbert’s syndrome, affecting 3–7% of the US
population (http://ghr.nlm.nih.gov/condition/gilbert-syndrome)
which is due to a genetic defect of UDP-glucuronyltranferase resulting in
decreased hepatic conjugation of bilirubin. In general, in asymptomatic,
healthy individuals who have mild unconjugated hyperbilirubinemia (<4
mg/dl), evaluation should exclude medications that cause hyperbilirubinemia,
exclude evidence of hemolysis, and confirm normal serum transaminases and alkaline
phosphatase levels. If these are found, then a presumptive diagnosis of
Gilbert’s syndrome can be made and additional evaluation is not routinely
necessary.
An isolated indirect hyperbilirubinemia
may also be seen in the setting of hemolysis where reduced serum haptoglobin
and elevated reticulocyte count and lactate dehydrogenase (LDH) level may be
present. However, hemolysis infrequently causes a bilirubin level >5 mg/dl,
unless co-existent renal disease, liver disease, or severe acute hemolysis is
present.2
In contrast to indirect
hyperbilirubinemia, conjugated (direct) hyperbilirubinemia generally implies
the presence of parenchymal liver damage or biliary obstruction. This is
associated with a number of hepatic disorders which result in decreased
excretion of bilirubin into the bile ducts, and leakage of bilirubin from
hepatocytes into the serum. Total serum bilirubin levels may exceed 30 mg/dl in
cases of severe liver damage, including alcoholic hepatitis with cirrhosis, and
may be seen in advanced cirrhosis patients with sepsis and/or renal failure.3-5
In addition, an isolated hyperbilirubinemia may be seen after major surgery and
typically resolves. 6 In hepatocellular jaundice, hepatocytes
are being destructed, conjugated bilirubin excretion into the bile capillaries
is impaired and it leaks into blood, where its level elevates significantly. The
approach to elevated bilirubin is shown in figure below.
There are two rare inherited conditions
associated with direct hyperbilirubinemia: Dubin–Johnson syndrome and Rotor
syndrome where the direct bilirubin is ~50% of the total with all other liver
tests being normal including alkaline phosphatase and GGT levels. It is not
necessary to distinguish between the two disorders. Dubin-Johnson syndrome
occurs due to a defect in the multidrug resistance canalicular enzyme while
Rotor syndrome appears to be related to defective bilirubin storage by
hepatocytes.7
Algorithm for evaluation of elevated serum total bilirubin
1.
Kwo PY, Cohen SM, Lim JK. ACG
Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J
Gastroenterol. 2017 Jan;112(1):18-35. doi: 10.1038/ajg.2016.517. Epub 2016 Dec
20
2.
Levine RA, Klatskin G .
Unconjugated hyperbilirubinemia in the absence of overt hemolysis: Importance
of acquired disease as an etiologic factor in 366 adolescent and adult
subjects. Am J Med 1964; 36:541 – 52
3.
O'Shea RS, Dasarathy S, McCullough
AJ. Alcoholic liver disease. Am J Gastroenterol 2010 ; 105 : 14 – 32; quiz 33.
4.
Chand N, Sanyal AJ. Sepsis-induced
cholestasis. Hepatology 2007;45: 230 – 41.
5.
Kantrowitz PA , Jones WA ,
Greenberger NJ , Isselbacher KJ . Greenberger and K.J. Isselbacher, Severe
postoperative hyperbilirubinemia simulating obstructive jaundice. N Engl J Med
1967; 276: 590 – 8.
6.
Schmid M, Hefti ML, Gattiker R et
al. Benign postoperative intrahepatic cholestasis. N Engl J Med 1965; 272: 545
– 50.
7.
Erlinger S , Arias IM , Dhumeaux D
. Inherited disorders of bilirubin transport and conjugation: new insights into
molecular mechanisms and consequences. Gastroenterology 2014; 146: 1625–38.
Published on 30 April 2024